9,10-Dihydroergocristine Methanesulfonate

Catalogue No.: IM061403
CAS No.: 24730-10-7
Mol. Formula: C₃₅H₄₁N₅O₅ • CH ₄O₃S

Description

Catalogue Number	IM061403
CAS No.	24730-10-7
Alternate CAS No.	17479-19-5
Chemical Name	9,10-Dihydroergocristine Methanesulfonate
Synonyms	(5'α,10α)-9,10-Dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-ergotaman-3',6',18-trione Methansulfonate; 9,10-Dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-ergotaman-3',6',18-trione Monomethanesulfonate; Dihydroergocristine Mesylate; Dihydroergocristine Methanesulfonate; 9,10-Dihydroergocristine Monomethanesulfonate; GNF Pf 3462; (6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-5-Benzyl-10b-hydroxy-2-isopropyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide Methanesulfonic Acid
Molecular Formula	C₃₅H₄₁N₅O₅ • CH ₄O₃S
Molecular Weight	611.73 + 96.10
Appearance	White to Off-White Solid
Melting Point	>187ºC (dec.)
Storage	4°C
Solubility	Chloroform (Slightly), Methanol (Slightly)
Applications	9,10-Dihydroergocristine Methanesulfonate is a nontoxic and well tolerated drug that exerts agonistic and antagonistic activity on dopaminergic and adrenergic receptors. 9,10-Dihydroergocristine Methanesulfonate is known to exhibit protective properties to the brain against metabolic effects of ischemia by acting at a cellular level.
Category	Standards; Pharmaceutical/API Drug Impurities/Metabolites; Lysergic Acid Derivatives; Tryptamines;

Note: All Products are stable to be shipped at room temperature, unless otherwise specified.